FINESSE: Fremanezumab for Preventive Treatment in Migraine

被引：0
|
作者：
Straube, A. [1 ]
Broessner, G. [2 ]
Gaul, C. [3 ]
Hamann, X. [4 ]
Kraya, T. [5 ]
Schauerte, I. [6 ]
Neeb, L. [7 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Neurol, Munich, Germany
[2] Med Univ Innsbruck, Neurol, Innsbruck, Austria
[3] Migrane & Kopfschmerz Klin Konigstein, Koenigstein, Germany
[4] Teva GmbH, Ulm, Germany
[5] Klinikum St Georg, Klin & Poliklin Neurol, Leipzig, Germany
[6] Inst Dr Schauerte, Munich, Germany
[7] Charite, Neurol, Berlin, Germany
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0325
引用
收藏
页码：174 / 175
页数：2
相关论文
共 50 条
  • [11] Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response
    Pazdera, Ladislav
    Cohen, Joshua M.
    Ning, Xiaoping
    Campos, Verena Ramirez
    Yang, Ronghua
    Pozo-Rosich, Patricia
    [J]. CEPHALALGIA, 2021, 41 (10) : 1075 - 1088
  • [12] Early Onset of Action with Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine
    Brandes, Jan
    Yeung, Paul P.
    Aycardi, Ernesto
    Bigal, Marcelo
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    [J]. NEUROLOGY, 2018, 90
  • [13] Early Onset of Action with Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine
    Yeung, Paul
    Aycardi, Ernesto
    Bigal, Marcelo
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    Brandes, Jan
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [14] Early Onset of Action with Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine
    Yeung, Paul P.
    Aycardi, Ernesto
    Bigal, Marcelo
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    Brandes, Jan
    [J]. NEUROLOGY, 2018, 90
  • [15] Fremanezumab for preventive treatment of migraine Functional status on headache-free days
    VanderPluym, Juliana
    Dodick, David W.
    Lipton, Richard B.
    Ma, Yuju
    Loupe, Pippa S.
    Bigal, Marcelo E.
    [J]. NEUROLOGY, 2018, 91 (12) : E1152 - E1165
  • [16] Early Onset of Action with Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine
    Yeung, Paul
    Aycardi, Ernesto
    Bigal, Marcelo
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    Brandes, Jan
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [17] Early Onset of Action with Fremanezumab versus Placebo for the Preventive Treatment of Chronic Migraine
    Brandes, J.
    Yeung, P. P.
    Aycardi, E.
    Bigal, M.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    [J]. HEADACHE, 2018, 58 : 89 - 89
  • [18] Early Onset of Action with Fremanezumab versus Placebo for the Preventive Treatment of Episodic Migraine
    Brandes, J.
    Yeung, P. P.
    Aycardi, E.
    Bigal, M.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    [J]. HEADACHE, 2018, 58 : 103 - 103
  • [19] Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines
    Cohen, Joshua M.
    Dodick, David W.
    Yang, Ronghua
    Newman, Lawrence C.
    Li, Thomas
    Aycardi, Ernesto
    Bigal, Marcelo E.
    [J]. HEADACHE, 2017, 57 (09): : 1375 - 1384
  • [20] Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
    Ashina, M.
    Mitsikostas, D.
    Amin, F. M.
    Kokturk, P.
    Sahin, G.
    Schankin, C.
    Dorman, P.
    Pozo-Rosich, P.
    Lyras, L.
    Myers, C.
    Ahn, A.
    Tassorelli, C.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
12345